Understanding the Impact of the Specialty Pharmacist on Quality and Effective Medication Management in Multiple Sclerosis
Understanding the Impact of the Specialty Pharmacist on Quality and Effective Medication Management in Multiple Sclerosis
Sarah Anderson, PharmD
Clinical Program Pharmacist
Medica Health Plans
Minnetonka, Minnesota
Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP
Director of Specialty Clinical Services
Managed Health Care Associates, Inc (MHA)
Florham Park, New Jersey
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose.
Faculty
Sarah Anderson, PharmD, and Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP
Pharmacy Times Office of Continuing Professional Education Planning Staff—David Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Donna Fausak; and Nathalie Harden
Specialty Pharmacy Times Editorial Staff—Davy James
An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Objectives
After participating in this activity, participants should be able to:
- Explain the pathophysiology, clinical presentation, and economic burden associated with MS
- Illustrate current treatment options for MS and emerging therapies
- Analyze potential opportunities for the specialty pharmacist to provide disease awareness through effective patient education to optimize adherence and improve outcomes
Target audience: Pharmacists
Type of activity: Application
Release date: August 12, 2015
Expiration date: August 12, 2016
Estimated time to complete activity: 1.0 hours
Fee: This lesson is offered for free at www.pharmacytimes.org.
https://www.pharmacytimes.org/landing/688
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.1 CEU) under the ACPE universal activity number 0290-0000-15-088-H01-P. The activity is available for CE credit through August 12, 2016.
